Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02133651 · ClinicalTrials.gov registry record
Mucosal Versus Fecal Microbiota in FMT
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 10
- Enrollment target
NCT02133651 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 10 participants.
The verdict
NCT02133651 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Clostridium difficile infection is the most common cause of antibiotic-associated diarrhea. Treatment of this infection usually occurs using other antibiotics, but many individuals have persistent diarrhea and multiple relapses. Fecal Transplant (FMT), or Intestinal Microbiota Transplantation, (IMT) has been shown to be efficacious when administered after treatment for C. difficile. This study will involve taking biopsies from patients during their FMT/IMT via colonoscopy, and determine if there are differences in the mucosal flora as compared to the stool flora. The investigators hope to discover the critical parts of a healthy microbiota.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02133651
The ClinicalTrials.gov registry entry for NCT02133651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02133651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02133651 about?
NCT02133651 is a clinical study titled "Mucosal Versus Fecal Microbiota in FMT". Clostridium difficile infection is the most common cause of antibiotic-associated diarrhea. Treatment of this infection usually occurs using other antibiotics, but many individuals have persistent diarrhea and multiple relapses. Fecal Transplant (FMT), or Intestinal Microbiota Transplantation, (IMT)...
What is the current status of trial NCT02133651?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2014-04. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02133651?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.